Stockreport

UPDATE 1-Roche's Tecentriq fails trial in form of urothelial cancer [Reuters]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF UPDATE 1-Roche's Tecentriq fails trial in form of urothelial cancer (Adds background) ZURICH, Jan 24 (Reuters) - Roche’s immunotherapy Tecentriq failed a late-stage clin [Read more]